Integrated screening concept in women with genetic predisposition for breast cancer;Integriertes Fruherkennungskonzept bei Frauen mit genetischer Pradisposition fur Brustkrebs

Radiologe

Volumn 37, Issue 8, 1997, Pages 591-596

  Bick, U ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Breast cancer; Genetic disposition; Magnetic resonance imaging; Mammography; Screening; Ultrasound

Indexed keywords

ARTICLE; BREAST CANCER; CANCER RISK; CANCER SCREENING; CANCER SUSCEPTIBILITY; DIAGNOSTIC TEST; ECHOMAMMOGRAPHY; GENETIC PREDISPOSITION; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; BREAST SELF EXAMINATION; BREAST TUMOR; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MASS SCREENING; PHYSIOLOGY; REVIEW; RISK FACTOR;

BRCA1 PROTEIN; BRCA2 PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; BREAST SELF-EXAMINATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; MAMMOGRAPHY; MASS SCREENING; NEOPLASM PROTEINS; RISK FACTORS; TRANSCRIPTION FACTORS; ULTRASONOGRAPHY, MAMMARY;

EID: 0030752153     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050258     Document Type: Article

References (40)

1. Athma P, Rappaport R, Swift M (1996) Molecular genotyping shows that ataxiateleangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92:130-134
2. Baker LH (1982) Breast Cancer Detection Demonstration Project: five-year summary report. CA Cancer J Clin 32:194-225
3. Bhatia S, Robison LL, Oberlin O, Greenberg M, Bunin G, Fossati-Bellani F, Meadows AT (1996) Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 334:745-751
4. Beckmann MW, Niederacker D, Goecke TO, Bodden-Heidrich R, Schnürch H-G, Bender HG (1997) Hochrisikofamilien mit Mamma- und Ovarialkarzinomen. Dtsch Ärztebl 94:A161-A167
5. Beckmann MW, Schnurch HG, Bodden-Heidrich R, Mosny DS, Crombach G, Nitz U, Achnoula M, Bender HG (1996) Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines. Eur J Cancer Prevent 5:468-475
6. Boice JDJ, Land CE, Shore RE, Norman JE, Tokunaga M (1979) Risk of breast cancer following low-dose radiation exposure. Radiology 131: 589-597
7. Burhenne HJ, Warren Burhenne L, Goldberg F, Hislop TG, Worth AJ, Rebbeck PM, Kan L (1994) Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification. AJR162:1067 1071
8. Champion V (1992) The role of breast cancer self-examination in breast cancer screening. Cancer 69:1985-1991
9. de Wolf CJM, Perry NM (1996) European guidelines for quality assurance in mammography screening, 2nd ed. Office for Official Publications of the European Communities, Luxembourg
10. Fischer U, Vosshenrich R, Bruhn H, Keating D, Raab BW, Oestmann JW (1995) MR-guided localization of suspected breast lesions detected exclusively by postcontrast MRI. J Comput Assist Tomogr 19:63-66
11. Flechter SW, Black W, Harris R, Rimer BK, Shapiro S (1993) Report of the International Workshop on Screening for Breast Cancer. J Natl Cancer Inst 85:1644-1656
12. Gayther SA, Mangion J, Russell P, Seal S, Barfoot R, Ponder BAJ, Stratton MR, Easton D (1997) Variation of risks of breast and ovarian cancer associated with different germline mutations of BRCA2 gene (letter). Nature Genetics 15: 103-105
13. Greene MH (1997) Genetics of breast cancer. Mayo Clin Proc 72:54-65
14. Hancock SL, Tucker MA, Hoppe RT (1993) Breast cancer after treatment of Hodgkin's disease. J Natl Cancer Inst 85:25-31
15. Heywang-Köbrunner SH, Huynh AT, Viehweg P, Hanke W, Requardt H, Paprosch I (1994) Prototype breast coil for MR-guided needle localization. J Comput Assist Tomogr 18: 876-881
16. Heywang-Köbrunner SH, Viehweg P (1994) Sensitivity of contrast-enhanced MR imaging of the breast. MRI Clin North Am 2:527-538
17. Hoskins KF, Stopfer JE, Calzone KA, Merajver SD, RebbeckTR, Garber JE, Weber BL (1995) Assessment and counseling for women with a family history of breast cancer. JAMA 273:577 585
18. Jackson VP (1995) The current role of ultra-sonography in breast imaging. Radiol Clin North Am 33:1161-1170
19. Kopans DB (1994) Screening for breast cancer and mortality reduction among women 40-49 years of age. Cancer 74:311-322
20. Kopans DB, Feig SA (1993) The Canadian National Breast Screening Study: a critical review. AJR 161:755-760
21. Ma L, Fishell E, Wright B, Hanna W, Allan S, Boyd NF (1992) A controlled study of the factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst 84: 781-785
22. Madjar H, Makowiec U, Mundinger A, DuBois A, Kommoss F, Schillinger H (1994) Einsatz der hochauflösenden Sonographie zur Brustkrebsvorsorge. Ultraschall Med 15:20-23
23. Madjar H, Sauerbrei W, Rachowska A, Pfleiderer A (1991 ) Vergleich von hochauflösender Sonographie und Mammographie. Ultraschall Klin Prax 6:290-297
24. Marcus JN, Watson P, Page DL, Narod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT (1996) Hereditaty breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77:697-709
25. Moskowitz M (1986) Breast cancer: age-specific growth rates and screening strategies. Radiology 161: 37-41
26. Noguchi M, Rose DP, Miyazaki I (1996) Breast cancer chemoprevention: clinical trials and research. Oncology 53:175-181
27. O'Shaughnessy JA (1996) Chemoprevention of breast cancer. JAMA 275:17
28. Orel SG, Schnall MD, Newman RW, Powell CM, Torosian MH, Rosato EF (1994) MR imaging-guided localization and biopsy of breast lesions: initial experience. Radiology 193: 97-102
29. Osteen RT, Karnell LH (1994) The National Cancer Data Base report on breast cancer. Cancer 73:1994-2000
30. Parker SH, Stavros AT, Dennis MA (1995) Needle biopsy techniques. Radiol Clin North Am 33: 1171-1186
31. Piccoli CW (1994) The specificity of contrast-enhanced breast MR imaging. MRI Clin North Am 2:557-571
32. Rotten D, Levaillant JM, Le Floch JP, Constancis E, André JM (1988) Mass screening for breast cancer with sonomammography: a prospective study. Eur J Obstet Gynecol 28:257-267
33. Serova OM, Mazoyer S, Puget N, Dubois V, Tonin P, Shugart YY, Goldgar D, Narod SA, Lynch HT, Lenoir CM (1997) Mutations in BRCA1 and BRC2 in breast cancer families: are there more breast cancer-susceptibility genes? Am J Hum Genet 60:486-495
34. Shapiro S (1994) Screening: assessment of current studies. Cancer 74:231-238
35. Stratton MR (1996) Recent advances in understanding of genetic susceptibility to breast cancer. Hum Mol Genet 5:1515-1519
36. Thomas DB, Gao DL, Self SG, Allison CJ, Tao Y, Mahloch J, Ray R, Quin Q, Presley R, Porter P (1997) Randomized trial of breast self-examination in shanghai: methodology and preliminary results. J Natl Cancer Inst 89:355-365
37. von Fournier D, Anton H-W, Junkermann H, BastertG, van KaickG (1993) Brustkrebsscreening. Wissensstand und Einführung als Vorsorgeleistung. Radiologe 33:227-235
38. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarström L, Webster ADB, Zaloudik J, BarbantiDrodano G, James M, Russo G, Croce CM, Negrini M (1996) The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56:2726-2732
39. Weber BL, Giusti RM, Liu ET (1995) Developing strategies for intervention and prevention in hereditary breast cancer. J Natl Cancer Inst Monogr 17:99-102
40. Winchester DP (1992) Physical examination of the breast. Cancer 69:1947-1949